Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Viking Therapeutics, Inc. Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $826 Billion
- Q4 2024
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 267,464 shares of VKTX stock, worth $7.09 Million. This represents 1.3% of its overall portfolio holdings.
Number of Shares
267,464
Previous 493,950
45.85%
Holding current value
$7.09 Million
Previous $31.3 Billion
65.58%
% of portfolio
1.3%
Previous 4.34%
Shares
4 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$270 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$160 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$131 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$68.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$57.2 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.03B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...